Search Results

Displaying Results 5651-5675 of 20712 "'R'"

Jun 22, 2026, 03:06 ET Share buybacks in Ericsson during the period June 15 - June 19, 2026

https://news.cision.com/ericsson/r/share-buybacks-in-ericsson-during-the-period-june-15---june-19--2026,c4365900The following files are available for download:

More news about: Ericsson


Jun 22, 2026, 03:06 ET Repurchase of Truecaller B shares in week 25, 2026

https://news.cision.com/truecaller-ab/r/repurchase-of-truecaller-b-shares-in-week-25--2026,c4365921The following files are available for download:

More news about: Truecaller AB


Jun 22, 2026, 03:03 ET Share buybacks in Ericsson during the period June 15 - June 19, 2026

https://news.cision.com/ericsson/r/share-buybacks-in-ericsson-during-the-period-june-15---june-19--2026,c4365900The following files are available for download:

More news about: Ericsson


Jun 22, 2026, 02:00 ET BioArctic and Lilly sign research and collaboration agreement combining Lilly compound with BioArctic's BrainTransporter™ technology

https://news.cision.com/bioarctic/r/bioarctic-and-lilly-sign-research-and-collaboration-agreement-combining-lilly-compound-with-bioarcti,c4365925The following files are available for download:

More news about: BioArctic


Jun 22, 2026, 01:52 ET BioArctic and Lilly sign research and collaboration agreement combining Lilly compound with BioArctic's BrainTransporter™ technology

https://news.cision.com/bioarctic/r/bioarctic-and-lilly-sign-research-and-collaboration-agreement-combining-lilly-compound-with-bioarcti,c4365925The following files are available for download:

More news about: BioArctic


Jun 22, 2026, 01:45 ET Translational Research Results of Sacituzumab Tirumotecan (sac-TMT) in Combination with Osimertinib as First-Line Treatment for EGFR-Mutant NSCLC Published in Cancer Cell

by MSD.About Kelun-BiotechKelun-Biotech (6990.HK) is a holding subsidiary of Kelun Pharmaceutical, which focuses on the R&D, manufacturing, commercialization and global collaboration of innovative biological drugs and small molecule drugs. Kelun-Biotech focuses on major

More news about: Kelun-Biotech


Jun 22, 2026, 00:37 ET Insilico Medicine And SK Biopharmaceuticals Achieved AI-powered Drug Discovery Collaboration Worth Up to 2.5 Billion for Neuroimmune Disorders

Through open innovation and collaborations with leading global institutions and companies, the company continues to expand its innovation ecosystem and R&D capabilities.SK Biopharmaceuticals is also leveraging AI and digital technologies across the drug discovery, development, and treatment continuum

More news about: Insilico Medicine


Jun 22, 2026, 00:02 ET Giti Tire launches GitiSynergy H3 on BMW iX1 and iX2 OE nominations

nominations with both the BMW 1 Series, supplying the GitiWinterW2 in size 225/40R19 93H XL and the BMW Group MINI, with the GitiSynergyH2 in 195/55R16 91W XL.Nicolas Kluson, Key Account Manager Europe OE for Giti Tire, said: "The OE Homologation

More news about: Giti Tire


Jun 21, 2026, 20:30 ET Antengene Announces Exclusive License Agreement with MPM BioImpact-Established K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE

on future net sales.About AntengeneAntengene Corporation Limited ("Antengene", SEHK: 6996.HK) is a global, R&D-driven, commercial-stage biotech company focused on developing first-in-class/best-in-class therapeutics for diseases with significant unmet medical needs.

More news about: Antengene Corporation Limited


Jun 21, 2026, 20:00 ET Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma

antibody with independent intellectual property rights for the treatment of R/R/MM in China. Furthermore, IBI3003 is also the second tri-specific antibody globally to have advanced into pivotal Phase III clinical development in the R/R MM setting. Although multiple myeloma has multiple treatment options, the

More news about: Innovent Biologics


Jun 21, 2026, 01:39 ET /C O R R E C C I O N -- Rokid/

More news about: Rokid


Jun 21, 2026, 01:25 ET THE WEEKND KICKS OFF EUROPEAN LEG OF RECORD-BREAKING AFTER HOURS TIL DAWN TOUR WITH TWO SOLD-OUT SHOWS AT COPENHAGEN'S PARKEN STADIUM

Nov 4 — Kuala Lumpur — TM Stadium NationalThu Nov 5 — Kuala Lumpur — TM Stadium NationalABOUT THE WEEKND:Filtering R&B and pop through an ambitious widescreen lens, The Weeknd took over popular music and culture on his own terms. The multi-platinum and 7x Diamond certified

More news about: Republic Records


Jun 21, 2026, 00:57 ET THE WEEKND KICKS OFF EUROPEAN LEG OF RECORD-BREAKING AFTER HOURS TIL DAWN TOUR WITH TWO SOLD-OUT SHOWS AT COPENHAGEN'S PARKEN STADIUM

Nov 4 — Kuala Lumpur — TM Stadium NationalThu Nov 5 — Kuala Lumpur — TM Stadium NationalABOUT THE WEEKND:Filtering R&B and pop through an ambitious widescreen lens, The Weeknd took over popular music and culture on his own terms. The multi-platinum and 7x Diamond certified

More news about: Republic Records


Jun 20, 2026, 20:52 ET CureGene Achieves First Participant Dosed in U.S. Pivotal Trial for Evategrel (CG-0255), a Best-in-Class Antiplatelet Drug, Accelerating Global Commercialization

Pharmaceutical"The first participant dosing in our U.S. pivotal trial of Evategrel is a major milestone in CureGene's journey of global innovative drug R&D. Cardiovascular and cerebrovascular diseases remain the leading cause of mortality and disability worldwide, and current treatment options have substantial

More news about: CureGene


Jun 20, 2026, 13:42 ET /C O R R E C T I O N -- Rokid/

More news about: Rokid


Jun 20, 2026, 10:10 ET HelloNation Clarifies Ohio Waiver Waiting List Classifications For Adults With Disabilities, Featuring Home Healthcare Expert Kellan Roberts Of Canton, Ohio

an article featuring insights from Home Healthcare Expert Kellan Roberts of R House Home Health Care Services in Canton, Ohio.

More news about: HelloNation


Jun 19, 2026, 18:02 ET INTCO Medical présente ses consommables médicaux, ses équipements de rééducation et ses solutions de kinésithérapie au salon WHX Miami 2026

l'un des principaux fabricants mondiaux de gants jetables. En tant qu'entreprise de fabrication de haute technologie, INTCO est spécialisée dans la R&D, la production et la commercialisation de consommables médicaux et de dispositifs médicaux durables. Pour plus d'informations, rendez-vous sur 

More news about: INTCO MEDICAL


Jun 19, 2026, 15:35 ET /C O R R E C T I O N -- Crayola/

More news about: Crayola


Jun 19, 2026, 12:29 ET Hexagon Composites ASA: Preliminary results of Subsequent Offering

https://news.cision.com/hexagon-composites-asa/r/hexagon-composites-asa--preliminary-results-of-subsequent-offering,c4365858

More news about: Hexagon Composites ASA


Jun 19, 2026, 11:20 ET /C O R R E C T I O N -- Barbarian/

also a member of the 4As AI Committee and Kai Tier, executive director of enterprise creative technology & AI who recently joined Barbarian from R/GA. Rounding out the team is new hire Dave Becker, who joins Barbarian from Huge, as director of strategic alliances. Dave will spearhead the integration

More news about: Barbarian


Jun 19, 2026, 11:00 ET Inside the $5.4 Billion Georgia-Israel Economic Corridor: 5W Releases Israeli Tech in Georgia 2026 -- 30 Years, 50+ Companies, and a New Generation of Builders

Coca-Cola (whose Tel Aviv-based Bridge accelerator is one of the most consistent Israeli-tech-into-Atlanta channels), Southern Company (whose 2018 R&D MoU with the Israel Innovation Authority covers vehicle automation, advanced materials, sustainable energy, public safety, smart homes, and distributed

More news about: 5W Public Relations


Jun 19, 2026, 10:28 ET CGTN: Chiny i Mjanma uzgodniły pogłębienie wszechstronnej pragmatycznej współpracy

PEKIN, 19 czerwca 2026 r. /PRNewswire/ -- Wyznaczając nowy etap w relacjach dwustronnych, prezydent Mjanmy Min Aung Hlaing zakończył swoją pierwszą wizytę państwową w Chinach, która odbyła się w dniach 15-19 czerwca. Wizyta

More news about: CGTN


Jun 19, 2026, 10:05 ET Amity University Bengaluru and L&T Technology Services sign a strategic MoU to establish E-mobility Centre of Excellence

organizations.The ceremony was attended by Mr. Vasu M., Head – EV Division, LTTS; Mr. Nikhil Dev B. R., Innovation Program Manager, LTTS; Dr. S. V. S. Phani Kumar, Technical Lead – R&D, LTTS; Dr. P. S. Sali, Vice President – Ritnand Balved Education Foundation, Amity Education Group; Dr. Monit

More news about: Amity University Bengaluru


Jun 19, 2026, 09:37 ET /C O R R E C T I O N -- Guarda Wallet/

More news about: Guarda Wallet


Jun 19, 2026, 09:28 ET /C O R R E C T I O N -- Acurion/

More news about: Acurion


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.